Home > Insider Trading > Filing (0001181431-13-049817)

Filing Details

Accession Number:: 0001181431-13-049817
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-18 19:58:27
Reporting Period:: 2013-09-16

Filing Date:: 2013-09-18
Accepted Time:: 2013-09-18 19:58:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1365216	Sucampo Pharmaceuticals Inc.	SCMP	Pharmaceutical Preparations (2834)	133929237

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1384384	S&R Technology Holdings, Llc	7501 Wisconsin Avenue Suite 600E Bethesda MD 20814-6519		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2013-09-16	14,662	$5.64	24,924,602	No	4	S	Direct
Class A Common Stock	Disposition	2013-09-17	12,600	$5.73	24,912,002	No	4	S	Direct
Class A Common Stock	Disposition	2013-09-18	11,200	$5.69	24,900,802	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2012.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.61 to $5.72, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.68 to $5.79, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.63 to $5.77, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.